about
Prevalence of comorbidities in Mexican mestizo patients with rheumatoid arthritis.Congestive Heart Failure with Preserved Ejection Fraction in a Patient with Light Chain (AL) Amyloidosis and Multiple Myeloma.Assessment of six cardiovascular risk calculators in Mexican mestizo patients with rheumatoid arthritis according to the EULAR 2015/2016 recommendations for cardiovascular risk management.Round opacity as a presentation of pneumocystis jirovecii pneumonia in an HIV-infected patientPseudomyocardial Infarction in a Patient with Severe Diabetic Ketoacidosis and Mild HyperkalemiaGlobal longitudinal strain as a biomarker in diabetic cardiomyopathy. A comparative study with Gal-3 in patients with preserved ejection fractionThermal burn resulting from prolonged transcutaneous pacing in a patient with complete heart blockPeriodontal Disease, Systemic Inflammation and the Risk of Cardiovascular DiseaseComparison of statin eligibility according to the Adult Treatment Panel III, ACC/AHA blood cholesterol guideline, and presence of carotid plaque by ultrasound in Mexican mestizo patients with rheumatoid arthritisThe best cardiovascular risk calculator to predict carotid plaques in rheumatoid arthritis patientsA young male with progressive dyspnea: Ebstein's anomalyA tick beat in the electrocardiogram: Persistent third degree block as only manifestation of Lyme diseaseClinical outcomes and biochemical characteristics of a Hispanic cohort of patients with diabetic ketoacidosis: 10-Year experience in an emergency departmentPrevalence and outcome of diuretic resistance in heart failure: commentLeprosy reactions in North-East Mexico: epidemiology and risk factors for chronic erythema nodosum leprosumToluene toxicity presenting with hypokalemia, profound weakness and U waves in the electrocardiogram
P50
Q38691780-45CA54BF-6C94-4AF6-8A7A-2AFFDBF3DD52Q41072464-9711CA0F-953A-4726-BBB5-B305168371A9Q47988471-C511DC5D-1FB3-45A8-AE4B-84841BC42D8AQ57063536-1126EFA2-69F2-45A1-BC1F-CC752CD81BB0Q64098685-063BF87E-A751-4B54-A724-957F775ECF50Q87845077-3EB8DB1C-AD09-4F2A-8AC2-4102EA797DEDQ88461226-5C89FF88-C8C5-4C80-87F7-A69787F0B6E8Q89107153-E27BDA04-661B-4F56-A44C-06350EA4CB44Q89278102-F9AE065A-F7CF-4CD6-A6C7-28695A0C7A9FQ89396588-50DF3BD4-66CB-4AEF-ACE1-2F69113B8BD8Q90319099-9216CA56-90D5-4BC2-A902-36B31A171F79Q90506902-231AC338-C5D0-4633-86FA-1A14083F6C95Q91781684-8B14FC8A-3160-4A86-B047-51D4F4B27CD3Q91785232-53275F33-2AD1-4037-8F7A-9CE1639CE5DCQ92685031-F470C72E-30A7-47F8-AA16-DC8C0345112CQ93061649-21AFCE6F-D677-4BCB-9DBD-E93469CFB7B4
P50
description
researcher
@en
wetenschapper
@nl
name
Raymundo Vera-Pineda
@en
Raymundo Vera-Pineda
@nl
type
label
Raymundo Vera-Pineda
@en
Raymundo Vera-Pineda
@nl
prefLabel
Raymundo Vera-Pineda
@en
Raymundo Vera-Pineda
@nl
P31
P496
0000-0003-4835-7511